↑ Rising
Business
🔮 holds
FDA approves Vera Therapeutics kidney disease treatment
FDA approval of Vera Therapeutics' kidney disease drug sparks market competition and patient hope
Fda Approval
3 trends tracked about this subject — the full history, oldest to newest below.
▲ Peaking
Business
🔮 fades
Why Psychedelics-Tied Compass Pathways Isn't Getting High
Compass Pathways' psychedelic depression drug shows promise—but its stock isn’t rising. Why?
◼ Archived
Health
🔮 fades ✓
One Specific Blood Protein Can Identify Dementia Risk Decades Before Diagnosis
A single blood protein could redefine Alzheimer’s detection—decades before symptoms appear.